Voriconazole therapeutic drug monitoring including analysis of CYP2C19 phenotype in immunocompromised pediatric patients with invasive fungal infections Matylda ResztakPaulina ZalewskaFranciszek K. Główka Research Open access 06 September 2024
Fixed parameters in the population pharmacokinetic modeling of valproic acid might not be suitable: external validation in Chinese adults with epilepsy or after neurosurgery Ruoyun WuKai LiShenghui Mei Research 29 August 2024
Reference guides for the safe use of drugs during pregnancy: a systematic review and comparative analysis Xue-Feng JiaoPanda QiuLingli Zhang Review 26 August 2024
Evaluation of pharmacokinetic target attainment and hematological toxicity of linezolid in pediatric patients Manal AbouelkheirMaram R. AldawsariAbdullah Alsultan Research 25 August 2024
Correction to: Use of antibiotics in the early COVID‑19 pandemic in Poland, the Netherlands and Spain, from erraticism to (more) logic Aleksandra OpalskaHelga GardarsdottirHubert Leufkens Correction Open access 22 August 2024
Prognostic effect of a vasopressin V2 receptor antagonist in acute congestive heart failure patients with hypoperfusion, the wet–cold pattern Kenichi MatsushitaKazumasa HaradaMorimasa Takayama Research 21 August 2024
Serious gaming as potential training tool for recognition of adverse drug reactions: side-effect exposure—medical education (SeeMe) Ingmar BergsLaura BellKatja S. Just Research Open access 19 August 2024
Evaluation of SLC6A2 and CYP2D6 polymorphisms’ effects on atomoxetine treatment in attention deficit and hyperactivity disorder Ismail Hasan KolePınar VuralCaner Mutlu Research 19 August 2024
Model-informed dose optimization of mycophenolic acid in pediatric kidney transplant patients Astrid HeidaNynke G. L. JagerRob ter Heine Research Open access 17 August 2024
Therapeutic drug monitoring for valproate: deriving a novel formula for calculation of free concentration Erna PretoriusPaulina van ZylGina Joubert Research Open access 16 August 2024
Short-term usage of proton pump inhibitors during admission was associated with increased risk of rehospitalization in critically ill patients with myocardial infarction: a cohort study Jia-De ZhuLi-Juan YangGong-Hao He Research 14 August 2024
Characteristics of isoniazid-induced psychosis: a systematic review of case reports and case series Keerthanaa BRashmi AppajiMahadev Rao Research Open access 13 August 2024
Reliability and validity of the Turkish version of the medication practical barriers to adherence questionnaire in patients with chronic diseases Nora SamuelyanPınar AyBetul Okuyan Research 07 August 2024
Efficacy and safety of ramucirumab for gastric or gastro-esophageal junction adenocarcinoma: a systematic review and meta-analysis Ruiqi RenZhewei ZhangJingzhou Wang Research 05 August 2024
Drug administration via feeding tubes—a procedure that carries risks: systematic identification of critical factors based on commonly administered drugs in a cohort of stroke patients Jana SommerfeldtHannes SartoriusChristoph A. Ritter Review Open access 29 July 2024
Neuronal toxicity of monoclonal antibodies (mAbs): an analysis of post-marketing reports from FDA Adverse Event Reporting System (FAERS) safety database Nitin KumarVivekanandan KalaiselvanMandeep Kumar Arora Research 25 July 2024
Correction to: Immune‑related serious adverse events with immune checkpoint inhibitors: systematic review and network meta‑analysis Clara OliveiraBeatrice MainoliJoão Costa Correction Open access 24 July 2024
Author’s reply to the letter to the editor: “Effects of dapagliflozin and empagliflozin on 6‑min walk distance in heart failure with preserved and reduced ejection fraction: A systematic review and meta‑analysis of randomized controlled trials involving 2624 patients” Mohammad TanashatAlmothana ManasrahMohamed Abouzid Correspondence 23 July 2024
Letter to the editor: "Effects of dapagliflozin and empagliflozin on 6-min walk distance in heart failure with preserved and reduced ejection fraction: a systematic review and meta-analysis of randomized controlled trials involving 2624 patients" Kazumasa KotakeKazuki AdachiYuki Nakano Correspondence 21 July 2024
No evidence of clinical efficacy of oxomemazine in cough, according to a systematic review Trystan BaconClara BlanchardRémy Boussageon Research 17 July 2024
Use of antibiotics in the early COVID-19 pandemic in Poland, the Netherlands and Spain, from erraticism to (more) logic Aleksandra OpalskaHelga GardarsdottirHubert Leufkens Research Open access 17 July 2024
Statin treatment for primary and secondary prevention in elderly patients—a cross-sectional study in Stockholm, Sweden Björn WettermarkCamelia KalantaripourPaul Hjemdahl Research Open access 16 July 2024
Effects of active vitamin D analogs and calcimimetic agents on PTH and bone mineral biomarkers in hemodialysis patients with SHPT: a network meta-analysis Xing LiuYichen LiuLimei Zhou Research 13 July 2024
Consumers’ knowledge and experiences of adverse drug reaction reporting in Australia: a national survey Mohammed Gebre DedefoRenly LimLisa Kalisch Ellett Research Open access 12 July 2024
Efficacy of cannabis-based medicine in the treatment of Tourette syndrome: a systematic review and meta-analysis Ibrahim SeragMona Mahmoud ElsakkaMohamed Abouzid Review Open access 10 July 2024
Efficacy and safety of different pharmacological interventions in the treatment of tardive dyskinesia: a systematic review and network meta-analysis Omar IsmailKaram AlbdourAmeen Alsaras Review 06 July 2024
Time-course and dose-effect of omalizumab in treating chronic idiopathic urticaria/chronic spontaneous urticaria Aiping ZhaoKe ZhangGuanghu Zhu Review 05 July 2024
Real-world safety and effectiveness of pirfenidone and nintedanib in the treatment of idiopathic pulmonary fibrosis: a systematic review and meta-analysis Mengjia KouYang JiaoWan Wei Review 04 July 2024
Impact of CYP2D6*2, CYP2D6*35, rs5758550, and related haplotypes on risperidone clearance in vivo Elisabet StørsetLine Skute BråtenMarianne Kristiansen Kringen Research Open access 04 July 2024
Effect of subcutaneous vs. intravenous tocilizumab in patients with severe COVID-19: a systematic review Yun LiXianlin LiXiaojun Zheng Research 27 June 2024
Risk of renal impairment in atypical antipsychotics: a systematic review and meta-analysis Leong Tung OngNicholas Ming Zher CheeAudrey Joe Chii Loh Review 25 June 2024
Use of drugs for hypertension or heart failure and the risk of death in COVID-19: association with loop-diuretics Johan FastbomGudrun Jonasdottir BergmanAnastasia Nyman Iliadou Research Open access 24 June 2024
Is atezolizumab plus bevacizumab as first-line therapy for unresectable hepatocellular carcinoma superior to lenvatinib? a systematic review and meta‑analysis Gang ZhuLongfei ZengTao Wu Review 22 June 2024
Risk of agranulocytosis with metamizole in comparison with alternative medications based on health records in Spain Miguel-Ángel Maciá-MartínezBelén Castillo-CanoElisa Martín-Merino Research 22 June 2024
Development and validation of individualized tacrolimus dosing software for Chinese pediatric liver transplantation patients: a population pharmacokinetic approach Siyu YangJian WeiXingang Li Research 21 June 2024 Pages: 1409 - 1420
Population pharmacokinetics of free and liposome-encapsulated mitoxantrone in patients with relapsed/refractory lymphoma or small cell lung cancer Gaoqi XuDihong YangLuo Fang Research 21 June 2024 Pages: 1399 - 1407
Effect of low-molecular-weight heparin calcium combined with magnesium sulfate and labetalol on coagulation, vascular endothelial function and pregnancy outcome in early-onset severe preeclampsia Yang LiuMiao ZhouJing Du Research 21 June 2024
Quantitative evaluation of the efficacy and safety profiles of two types of targeted inhibitors combined with endocrine therapy in ER+/HER2− metastatic breast cancer Meiyu PanYan LinJin Yang Research 20 June 2024 Pages: 1387 - 1397
Treatment-related adverse events in patients with advanced breast cancer receiving adjuvant AKT inhibitors: a meta-analysis of randomized controlled trials Francisco Cezar Aquino de MoraesVitor Kendi Tsuchiya SanoRommel Mario Rodríguez Burbano Research 18 June 2024 Pages: 1373 - 1385
Assessment of a systematic approach for implementing novel medications in clinical practice: an observational study with dapagliflozin Helena NorbergTherese AnderssonKrister Lindmark Research Open access 10 June 2024 Pages: 1363 - 1371
How can polymyxin B be dosed based on current pharmacokinetic knowledge? Huadong ChenZhenjiao ZhangZhenwei Yu Correspondence 07 June 2024 Pages: 1421 - 1423
Characteristics and preventability of medication-related admissions for acute kidney injury and dehydration in elderly patients Tristan CoppesAnkie C. M. HazenMarcel L. Bouvy Research Open access 03 June 2024 Pages: 1355 - 1362
Apixaban plasma concentrations in patients with obesity Fadiea Al-AieshyMika SkeppholmRickard E. Malmström Research Open access 01 June 2024 Pages: 1343 - 1354
Synergizing pharmacometrics and pharmacovigilance for medication error management: the case of secukinumab Yeleen FromageHamza SayadiJean-Baptiste Woillard Research 01 June 2024 Pages: 1339 - 1341
Population pharmacokinetic, pharmacodynamic and efficacy modeling of SB12 (proposed eculizumab biosimilar) and reference eculizumab Hyuna LeeJihye ParkJungryul Kim Research Open access 30 May 2024 Pages: 1325 - 1338
Clinical and biochemical characteristics, and outcome in 33 patients with ceftriaxone-induced liver injury Cai-Xia FengWen-Yu YeQing-Wen Shan Research 29 May 2024 Pages: 1317 - 1324
Trends in statin use for the primary prevention of atherosclerotic cardiovascular disease among US adults by demographic characteristics, 1999–2020 Junwen WangYuyang YeYong Peng Research 28 May 2024 Pages: 1305 - 1315
Population pharmacokinetics and dosage optimization of linezolid in Chinese older patients Yuanchen LiQiu FangHuaijun Zhu Research 27 May 2024 Pages: 1295 - 1304
Reliability and validity of the Swedish indicator ‘Drugs that should be avoided in older people’—an appraisal of a set of potentially inappropriate medications Naldy Parodi LópezStaffan A. SvenssonSusanna M. Wallerstedt Research Open access 14 May 2024 Pages: 1285 - 1293